<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 10 (filtered)">
<title>Nöropatik a&#287;r&#305;n&#305;n tedavisinde kullan&#305;lan ilaçlar</title>

<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";}
@page Section1
	{size:595.3pt 841.9pt;
	margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.Section1
	{page:Section1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-US>

<div class=Section1>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=center style='text-align:center;border:none;
padding:0cm'><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;border:none;
padding:0cm'><b><span lang=TR style='font-family:Tahoma'>NÖROPAT&#304;K
A&#286;RI</span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:150%;border:none;
padding:0cm'><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

</div>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>Nöropatik a&#287;r&#305;, santral veya periferik
sinir sistemindeki primer lezyonlara veya disfonksiyona ba&#287;l&#305; olarak
ortaya ç&#305;kan a&#287;r&#305; türüdür. Nöropatik a&#287;r&#305;, dokulardaki
hasarla ortaya ç&#305;kan nosiseptif a&#287;r&#305;dan farkl&#305; olarak,
sürekli bir uyarana ihtiyaç göstermez. A&#287;r&#305;y&#305; ba&#351;latan
etken  periferik sinir travmas&#305;, metabolik, inflamatuvar ve di&#287;er
etyolojik faktörlere ba&#287;l&#305; olu&#351;abilece&#287;i gibi benzer
etyolojilere ba&#287;l&#305; santral nedenlerden de kaynaklanabilir. Vü­cu­dun
her­han­gi bir ye­rin­de or­ta­ya ç&#305;­kan nö­ro­pa­tik a&#287;­r&#305; pe­ri­fe­rik
si­nir sis­te­mi, sant­ral si­nir sis­te­mi ve oto­nom si­nir sis­te­min­den
kay­nak­la­na­bi­lir. </span><span lang=ES style='font-family:Tahoma'>Oto­no­m
si­nir sis­te­mi de nö­ro­pa­tik a&#287;­r&#305;­da yay­g&#305;n ola­rak rol oy­na­mak­ta­d&#305;r.
Oto­nom si­nir sis­te­min­den kay­nak­la­nan nö­ro­pa­tik a&#287;­r&#305;­lar <i>komp­leks
bölgesel a&#287;­r&#305; send­rom­la­r&#305; </i>ad&#305;­ al­t&#305;n­da in­ce­len­mek­te­dir.
Sonuç olarak, al­t&#305;n­da oto­no­mik özel­lik­ler ol­sun ol­ma­s&#305;n si­nir
sis­te­min­den kay­nak­la­nan a&#287;­r&#305;­lar nö­ro­pa­tik a&#287;­r&#305;
ad&#305; al­t&#305;n­da top­lan­mak­ta­d&#305;r. </span><span lang=TR
style='font-family:Tahoma'>Nöropatik a&#287;r&#305; hasardan veya olu&#351;an
hasar&#305;n &#351;iddetinden ba&#287;&#305;ms&#305;z olarak devam edebilir ve
hatta haftalar, aylar, y&#305;llar içinde &#351;iddetlenebilir.
A&#287;r&#305;n&#305;n yanl&#305;&#351; tan&#305;mlanmas&#305;, yanl&#305;&#351;
lokalize edilmesi, alg&#305;laman&#305;n gecikmesi ve yay&#305;lma söz
konusudur. </span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>Nöropatik a&#287;r&#305;n&#305;n olu&#351;umunda rol
oynayan mekanizmalar <i>periferik ve santral</i> <i>mekanizmalar</i> olarak iki
grupta de&#287;erlendirilebilir. Periferik mekanizmalar içerisinde <i>periferik
sensitizasyon</i> (cerrahi giri&#351;im veya travmadan sonra haraplanan hücrelerden
salg&#305;lanan maddelerin yine baz&#305; ara maddelerle birlikte C liflerini
aktive etmesi ve P maddesinin salg&#305;lanmas&#305;), <i>ektopik
de&#351;arjlar</i> (herhangi bir etyolojiye ba&#287;l&#305; olarak geli&#351;en
sinir hasar&#305; sonras&#305; akson boyunca ektopik uyar&#305;lar&#305;n
olu&#351;mas&#305;), <i>aksonlar aras&#305; anormal etkile&#351;im</i>, <i>katekolaminlere
kar&#351;&#305; artm&#305;&#351; duyarl&#305;l&#305;k</i> gibi etkenler
say&#305;labilir. Santral mekanizmalar ise <i>duyusal yollar&#305;n veya
sempatik sistemin irritasyonu, hipotalamik bozukluk, inen inhibitör
mekanizmalar&#305;n disfonksiyonu ve ç&#305;kan yollar&#305;n
a&#351;&#305;r&#305; aktivasyonu</i> olarak say&#305;labilir.  </span></p>

<p class=MsoNormal style='text-indent:14.15pt'><b><span lang=ES
style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=ES style='font-family:Tahoma'>Periferik sinir
sisteminden kaynaklanan nöropatik a&#287;r&#305;lar:</span></b></p>

<p class=MsoNormal style='text-indent:14.15pt;line-height:7.0pt'><b><span
lang=ES style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=ES style='font-family:
Tahoma'>- Periferik sinire ait tümörler</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=ES style='font-family:
Tahoma'>- Si­nir bas&#305;s&#305;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=ES style='font-family:
Tahoma'>- Si­nir ezil­me­si, avül­si­yo­nu, ge­ril­mesi, ke­sil­mesi</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>- Nö­ro­pa­ti­ler (di­abe­tik nö­ro­pa­ti, rad­yas­yon
nö­ro­pa­ti­si, al­kol nö­ro­pa­ti­si, vaskülitik nö­ro­pa­ti gibi)</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><b><span lang=NO-BOK
style='font-family:Tahoma'>Santral sinir sisteminden kaynaklanan nöropatik
a&#287;r&#305;lar:</span></b></p>

<p class=MsoNormal style='text-indent:14.15pt;line-height:7.0pt'><b><span
lang=NO-BOK style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>- Medulla spi­nalis hastal&#305;klar&#305; (kon­tüz­yon,
is­ke­mi, tü­mör)</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>- Be­yin sa­p&#305;, ta­la­musu etkileyen patolojik
durumlar (in­farkt, tü­mör, trav­ma)</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><b><span
lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><b><span
lang=TR style='font-family:Tahoma'>NÖROPAT&#304;K A&#286;RI
TEDAV&#304;S&#304;NDE KULLANILAN AJANLAR </span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>Nöropatik a&#287;r&#305;n&#305;n tedavisinde kullan&#305;lan
ajanlar aras&#305;nda ba&#351;l&#305;ca antikonvülzanlar, trisiklik antidepresanlar,
opioid analjezikler, antiaritmikler, lokal anestezikler say&#305;labilir.
A&#351;a&#287;&#305;da  a&#287;r&#305;l&#305; duruma göre seçilmesi gereken ilaçlar
özetlenmi&#351;tir: </span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=503
 style='width:377.2pt;border:solid windowtext 1.0pt'>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;background:
  #D9D9D9;padding:0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;color:black'>A&#287;r&#305;l&#305;
  durum</span></b></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;background:
  #D9D9D9;padding:0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span lang=TR
  style='font-family:Tahoma;color:black'>&#304;lk s&#305;ra tedavi</span></b></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;background:
  #D9D9D9;padding:0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span lang=TR
  style='font-family:Tahoma;color:black'>2./3. s&#305;ra tedavi</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>A&#287;r&#305;l&#305;
  Nöropati</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Gabapentin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Pregabalin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>TSA</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Lamotrijin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Opioidler</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>SNRI</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Tramadol</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Postherpetik</span></p>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Nevralji</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Gabapentin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Pregabalin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Topikal Lidokain</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>TSA</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Kapsaisin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Opioidler</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Tramadol</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Valproat</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Trigeminal
  Nevralji</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Okskarbazepin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Karbamazepin</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Cerrahi</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Santral
  A&#287;r&#305;</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Amitriptilin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Gabapentin </span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Pregabalin</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Kannabinoidler</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Lamotrijin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Opioidler</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>TSA: trisiklik antidepresan;
SNRI: Serotonin-noradrenalin geri al&#305;n&#305;m inhibitörleri</span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:17.85pt;line-height:150%'><b><span
lang=TR style='font-family:Tahoma'>1- ANT&#304;EP&#304;LEPT&#304;KLER:</span></b></p>

<p class=MsoNormal style='margin-left:17.85pt;text-align:justify;line-height:
150%'><span lang=TR style='font-family:Tahoma'>Nöropatik a&#287;r&#305; tedavisinde
kullan&#305;lan antiepileptik ilaçlar aras&#305;nda <b>karbamazepin, okskarbazepin</b>,
<b>lamotrijin</b>, <b>gabapentin ve pregabalin </b>say&#305;labilir. Antiepileptikler
nöronal membranlar&#305; stabilize ederek, sinaptik inhibisyonu artt&#305;rarak
ya da sinaptik eksitasyonu azaltarak etki gösterirler. Karbamazepin ve okskarbazepin
voltaja-ba&#287;l&#305; sodyum kanal&#305;  inaktivasyonuna neden olur,
ayr&#305;ca her ikisi de eksitatör nörotransmiter sal&#305;n&#305;m&#305;n&#305;
azalt&#305;rlar<b>. Karbamazepinin </b>yan etkisi ve ilaç etkile&#351;imleri belirgindir,
otoindüksiyon yapar. Okskarbazepinin ise yan etkisi daha azd&#305;r. Her iki
ajan diyabetik nöropati, postherpetik nevralji, trigeminal nevraljide
kullan&#305;labilir. <b>Gabapentin</b> GABA konsantrasyonunu ve non veziküler
GABA sal&#305;n&#305;m&#305;n&#305; artt&#305;r&#305;r. Bunu N tipi Ca
kanallar&#305; arac&#305;l&#305;&#287;&#305;yla yapar. <b>Pregabalin </b>ise
voltaja ba&#287;l&#305; Ca kanal modülatörüdür, nörotransmiter sal&#305;n&#305;m&#305;n&#305;
azalt&#305;r. Lineer bir farmakokineti&#287;e sahiptir, 1-3 günde etkisi
ba&#351;lar, %90’a yak&#305;n bio-yararlan&#305;m söz konusudur. Renal
disfonksiyon varl&#305;&#287;&#305;nda doz ayar&#305; gerekebilir. Son
y&#305;llarda nöropatik a&#287;r&#305;da ilk s&#305;rada tercih edilen ajan
haline gelmi&#351;tir. Trisiklik antidepresanlar, gabapentin ve di&#287;er
tedavilere (SSRI (selektif</span><span lang=TR style='font-family:Tahoma'> serotonin
geri al&#305;n&#305;m inhibitörleri), SNRI (Serotonin-noradrenalin geri
al&#305;n&#305;m inhibitörleri), opioidler gibi) yetersiz yan&#305;t veren
hastalar&#305;n a&#287;r&#305; skorlar&#305;n&#305; anlaml&#305; derecede
düzeltti&#287;i görülmü&#351;tür.<i> </i></span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>2-
ANT&#304;DEPRESANLAR  </span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Trisiklik-</span></b><i><span
     lang=TR style='font-family:Tahoma'>Amitriptilin </span></i></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Yüksek dozlarda
etkilidir ve etki doza ba&#287;&#305;ml&#305;d&#305;r. Sürekli ve bat&#305;c&#305;
a&#287;r&#305;da etkilidir. &#304;skemik kalp hastalar&#305;nda ani aritmiye
yol aç&#305;p ölüme neden olabilir, bu nedenle özellikle ya&#351;l&#305; ve kardiyak
sorunu olan hastalarda dikkatli kullan&#305;lmal&#305;d&#305;r. Sedasyona,
a&#287;&#305;z kurulu&#287;una ve kilo art&#305;&#351;&#305;na yol açabilir.</span></p>

<p class=MsoNormal style='margin-left:18.0pt'><i><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></i></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>SSRI, SNRI </span></b></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>SSRI ve SNRI’lar 
a&#287;r&#305;l&#305; nöropatide baz&#305; çal&#305;&#351;malarda plasebodan  üstün
bulunmu&#351;tur. En s&#305;k kullan&#305;lan ajanlar Venlafaksin  (150-300 mg/gün)
ve Duloksetin’dir (1x60 mg/gün).</span></p>

<p class=MsoNormal style='margin-left:18.0pt'><i><span lang=TR
style='font-family:Tahoma'>     </span></i></p>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>3-
OP&#304;O&#304;DLER  </span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Tramadol</span></b></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Etkinli&#287;i orta
derecededir. Sürekli a&#287;r&#305; ve allodinide etkilidir. Etkin doz 100-200 mg/gün
olup, do&#287;rudan bu dozda ba&#351;lanabilir. Bulant&#305;-kusma ve
kab&#305;zl&#305;k gibi yan etkileri k&#305;s&#305;tlay&#305;c&#305; olabilir.</span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Fentanil</span></b><span
     lang=TR style='font-family:Tahoma'> <i>- transdermal flaster 25/50/75/100</i></span></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Etkinli&#287;i yüksektir
ve tek flaster 3 gün etkili olabilir. Yineleyen kullan&#305;mlarda
ba&#287;&#305;ml&#305;l&#305;k geli&#351;ebilir. Yan etkileri Tramadol’le
ayn&#305;d&#305;r. </span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>4- ANT&#304;AR&#304;TM&#304;KLER</span></b></p>

<p class=MsoNormal style='margin-left:18.0pt'><b><span lang=TR
style='font-family:Tahoma'> </span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Lidokain</span></b></li>
</ul>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>Nonspesifik bir Na kanal blokeridir, etkili olabilir fakat oral
verilemez.</span></p>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>&nbsp;</span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Meksiletin </span></b></li>
</ul>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>Lidokainin oral analo&#287;udur<b>. </b>Birkaç çal&#305;&#351;mada
plasebodan daha iyi sonuç vermi&#351;tir. Kullan&#305;m&#305; yayg&#305;n
de&#287;ildir.</span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>5- LOKAL
TEDAV&#304; </span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Kapsaisin</span></b></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Ac&#305; biberden
türetilmi&#351; bir alkaloiddir. Duysal nöronlardan substans P’yi
aç&#305;&#287;a ç&#305;kar&#305;p tüketerek ve epidermal sinir liflerini dejerene
ederek etki gösterir. Lokal yan etkileri olabilir. Zay&#305;f-orta derecede bir
etkinli&#287;e sahiptir ve ancak yard&#305;mc&#305; tedavi yöntemi olarak
önerilir.</span><b><span lang=TR style='font-family:Tahoma'>   </span></b></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

</div>

</body>

</html>
